Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Lightman, S.
and
Lynn, W.A.
2001.
Clinical microbiological case: visual problems in an HIV-positive patient.
Clinical Microbiology and Infection,
Vol. 7,
Issue. 11,
p.
653.
Shen, De Fen
Herbort, Carl P
Tuaillon, Nadine
Buggage, Ronald R
Egwuagu, Charles E
and
Chan, Chi-Chao
2001.
Detection of Toxoplasma Gondii DNA in Primary Intraocular B-Cell Lymphoma.
Modern Pathology,
Vol. 14,
Issue. 10,
p.
995.
Bosch-Driessen, Lotje E.H
Berendschot, Tos T.J.M
Ongkosuwito, Jenny V
and
Rothova, Aniki
2002.
Ocular toxoplasmosis.
Ophthalmology,
Vol. 109,
Issue. 5,
p.
869.
Bastien, Patrick
2002.
Molecular diagnosis of toxoplasmosis.
Transactions of the Royal Society of Tropical Medicine and Hygiene,
Vol. 96,
Issue. ,
p.
S205.
Blackwell, J.
Newbold, C.
Turner, M.
Vickerman, K.
Sibley, L. David
Mordue, Dana G.
Su, Chunlei
Robben, Paul M.
and
Howe, Dan K.
2002.
Genetic approaches to studying virulence and pathogenesis inToxoplasma gondii.
Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences,
Vol. 357,
Issue. 1417,
p.
81.
Bosch-Driessen, Lotje H
Verbraak, Frank D
Suttorp-Schulten, Maria S.A
van Ruyven, Rutger L.J
Klok, Anne Marie
Hoyng, Carel B
and
Rothova, Aniki
2002.
A prospective, randomized trial of pyrimethamine and azithromycin vs pyrimethamine and sulfadiazine for the treatment of ocular toxoplasmosis.
American Journal of Ophthalmology,
Vol. 134,
Issue. 1,
p.
34.
Stanford, Miles R
See, Sarah E
Jones, Leanne V
and
Gilbert, Ruth E
2003.
Antibiotics for toxoplasmic retinochoroiditis.
Ophthalmology,
Vol. 110,
Issue. 5,
p.
926.
Markus, Miles
2003.
International Handbook of Foodborne Pathogens.
Lu, Fangli
Huang, Shiguang
and
Kasper, Lloyd H.
2004.
CD4+T Cells in the Pathogenesis of Murine Ocular Toxoplasmosis.
Infection and Immunity,
Vol. 72,
Issue. 9,
p.
4966.
Holland, Gary N.
2004.
Ocular toxoplasmosis: a global reassessment.
American Journal of Ophthalmology,
Vol. 137,
Issue. 1,
p.
1.
Garweg, J. G.
2005.
Determinants of immunodiagnostic success in human ocular toxoplasmosis.
Parasite Immunology,
Vol. 27,
Issue. 3,
p.
61.
Pleyer, U.
Torun, N.
and
Liesenfeld, O.
2007.
Okuläre Toxoplasmose.
Der Ophthalmologe,
Vol. 104,
Issue. 7,
p.
603.
Dardé, M.L.
Ajzenberg, D.
and
Smith, J.
2007.
Toxoplasma Gondii.
p.
49.
Petersen, Eskild
2007.
Prevention and treatment of congenital toxoplasmosis.
Expert Review of Anti-infective Therapy,
Vol. 5,
Issue. 2,
p.
285.
Petersen, Eskild
2007.
Toxoplasmosis.
Seminars in Fetal and Neonatal Medicine,
Vol. 12,
Issue. 3,
p.
214.
2007.
Surveillance and monitoring of Toxoplasma in humans, food and animals - Scientific Opinion of the Panel on Biological Hazards.
EFSA Journal,
Vol. 5,
Issue. 12,
p.
583.
Petersen, E.
and
Liesenfeld, O.
2007.
Toxoplasma Gondii.
p.
81.
Gilbert, Ruth E.
Freeman, Katherine
Lago, Eleonor G.
Bahia-Oliveira, Lilian M. G.
Tan, Hooi Kuan
Wallon, Martine
Buffolano, Wilma
Stanford, Miles R.
Petersen, Eskild
and
Campos, Marco Antônio Silva
2008.
Ocular Sequelae of Congenital Toxoplasmosis in Brazil Compared with Europe.
PLoS Neglected Tropical Diseases,
Vol. 2,
Issue. 8,
p.
e277.
Garweg, Justus G
and
Peyron, François
2008.
Clinical and laboratory diagnosis of ocular toxoplasmosis.
Expert Review of Ophthalmology,
Vol. 3,
Issue. 3,
p.
333.
Wallace, G R
and
Stanford, M R
2008.
Immunity andToxoplasmaretinochoroiditis.
Clinical and Experimental Immunology,
Vol. 153,
Issue. 3,
p.
309.